Literature DB >> 25123570

West-African trypanosomiasis in a returned traveller from Ghana: an unusual cause of progressive neurological decline.

Ivo Elliott1, Trupti Patel2, Jagrit Shah3, Pradhib Venkatesan1.   

Abstract

West-African trypanosomiasis caused by Trypanosoma brucei gambiense is a rare imported infection presenting with somnolence, lymphadenopathy and wide-ranging neurological symptoms. A 67-year-old Caucasian man presented with a 10-month history of cognitive deterioration, ataxic gait, somnolence and urinary incontinence. His symptoms had progressed more rapidly over the course of a month prior to admission. Serological testing confirmed a diagnosis of West-African trypanosomiasis. The patient was successfully treated with eflornithine and made a good recovery. West-African trypanosomiasis should be considered in the differential diagnosis of unexplained cognitive decline in those with a relevant travel history. If left untreated, the condition is universally fatal. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25123570      PMCID: PMC4139564          DOI: 10.1136/bcr-2014-204451

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Lesson of the month: a psychiatric diagnosis overturned by a blood film.

Authors:  Emily Wise; Nicholas Easom; Julie Watson; Robin Bailey; Michael Brown
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

2.  Human African trypanosomiasis (sleeping sickness): epidemiological update.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-02-24

3.  Human African trypanosomiasis.

Authors:  Reto Brun; Johannes Blum; Francois Chappuis; Christian Burri
Journal:  Lancet       Date:  2009-10-14       Impact factor: 79.321

4.  Lethal African trypanosomiasis in a traveler: MRI and neuropathology.

Authors:  Hilde M H Braakman; Fred J J M van de Molengraft; Wim W A Hubert; Dolf H Boerman
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

5.  Sleeping sickness diagnosis: use of buffy coats improves the sensitivity of the mini anion exchange centrifugation test.

Authors:  Mamadou Camara; Oumou Camara; Hamidou Ilboudo; Hassan Sakande; Jacques Kaboré; Louis N'Dri; Vincent Jamonneau; Bruno Bucheton
Journal:  Trop Med Int Health       Date:  2010-05-21       Impact factor: 2.622

Review 6.  The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa.

Authors:  V Lejon; M Boelaert; J Jannin; A Moore; P Büscher
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

Review 7.  Human African trypanosomiasis-neurological aspects.

Authors:  Peter G E Kennedy
Journal:  J Neurol       Date:  2006-03-20       Impact factor: 4.849

Review 8.  Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature.

Authors:  Piet A Kager; Hans G Schipper; Jan Stam; Charles B L M Majoie
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

9.  Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.

Authors:  Gerardo Priotto; Serena Kasparian; Wilfried Mutombo; Daniel Ngouama; Sara Ghorashian; Ute Arnold; Salah Ghabri; Elisabeth Baudin; Vincent Buard; Serge Kazadi-Kyanza; Médard Ilunga; Willy Mutangala; Gabriele Pohlig; Caecilia Schmid; Unni Karunakara; Els Torreele; Victor Kande
Journal:  Lancet       Date:  2009-06-24       Impact factor: 79.321

Review 10.  Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review.

Authors:  Patrick Mitashi; Epco Hasker; Veerle Lejon; Victor Kande; Jean-Jacques Muyembe; Pascal Lutumba; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29
  10 in total
  1 in total

1.  Unusual MRI Findings in African Trypanosoma brucei gambiense Trypanosomiasis: Dentate Nuclei and Hypothalamic Lesions.

Authors:  Monique Boukobza; Sylvie Lariven; Sandrine Houzé; Jean-Pierre Laissy
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.